News
Discover the most recent news about our company
Abstract The study of nutritional interventions in humans is difficult to assess because the induced metabolic changes are lower than the natural biological variability between subjects. Due to its holistic…
Particle size measurement of lipoprotein fractions using diffusion-ordered NMR spectroscopy
2 December 2020
Abstract The sizes of certain types of lipoprotein particles have been associated with an increased risk of cardiovascular disease. However, there is currently no gold standard technique for the determination…
From LAB to market
18 November 2020
Last year we published 19 scientific articles in international journals. We are a metabolomics company halfway between research and clinical practice, a scientific research group in a business environment that…
Biosfer was awarded with the INNOWWIDE: a high competitive European call
9 November 2020
Recently our CEO, Núria Amigó, was invited to participate in the first INNOWWIDE Focus Group, a virtual meeting organized by Steinbeis 2i innovative + international, as an INNOWWIDE funding recipient…
GlycA as a new biomarker in rheumatoid arthritis
21 October 2020
The research group in Immunology at the University of Oviedo with the participation of Dr. Javier Rodríguez-Carrio has published a study in which one of the variables from our glycoprotein…
Advanced lipoprotein profile disturbances in type 1 diabetes mellitus: a focus on LDL particles
16 October 2020
Our lipoprotein profile, Liposcale (CE), in Cardiovascular Diabetology: “Advanced lipoprotein profile disturbances in type 1 diabetes mellitus: a focus on LDL particles” The research groups of Sant Pau and Hospital…
Our Liposcale test in clinical practice
13 October 2020
We are very happy to announce that the Spanish Arteriosclerosis Society has drawn up a consensus on the clinical use of Nuclear Magnetic Resonance for the study of lipoproteins using…
We are virtually at the European Arteriosclerosis Society congress
8 October 2020
This week the 88th edition of the Congress of the European Arteriosclerosis Society was held in virtual format. The congress has included a large number of basic and clinical research…
Glycoprotein Profile Assessed by 1H-NMR as a Global Inflammation Marker in Patients with HIV Infection. A Prospective Study.
24 September 2020
Abstract Plasma glycoproteins are a composite biomarker of inflammation and can be detected by 1H-NMR. The aim of this study was to prospectively appraise the clinical value of plasma glycoproteins…